Clinical Trials for GSK2141795

1 Open Trial

Trial TypeProtocol No. &
Open Date
Summary
TreatmentVICCPHI1333
09/18/2013
A Phase I Dose Escalation Open-Label Safety, Pharmacokinetic and Pharmacodynamic Study to Determine the Recommended Phase II Dose of GSK1120212 Dosed in Combination with GSK2141795

Back to Find By Drug

You do not have JavaScript enabled. This site works better with JavaScript turned on.